Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial.

Gabapentin for the Management of Chronic Pelvic Pain in Women (GaPP1): A Pilot Randomised Controlled Trial.

Chronic pelvic pain (CPP) affects 2.1-24% of women. Frequently, no underlying pathology is identified, and the pain is difficult to manage. Gabapentin is prescribed for CPP despite no robust evidence of efficacy. We performed a pilot trial in two UK centres to inform the planning of a future multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Steff C Lewis, Siladitya Bhattacharya, Olivia Wu, Katy Vincent, Stuart A Jack, Hilary O D Critchley, Maureen A Porter, Denise Cranley, John A Wilson, Andrew W Horne
Formato: Artículo
Lenguaje:English
Publicado: Public Library of Science (PLoS) 2016-01-01
Colección:PLoS ONE
Acceso en línea:https://doi.org/10.1371/journal.pone.0153037

Internet

https://doi.org/10.1371/journal.pone.0153037

Ejemplares similares